ÂÜÀòÂÒÂ×

The Scientific Team at Mnemo Therapeutics is responsible for conducting cutting-edge research to identify and validate new therapeutic targets for solid tumors and blood cancers. This multidisciplinary team leverages expertise in molecular biology, bioinformatics, computational biology, proteomics, immunology, and cell biology to develop and optimize the company's innovative EnfiniT platform. Their efforts aim to discover novel antigens and improve T cell therapies' memory, persistence, and sensitivity, driving the advancement of powerful immune therapies to provide accessible cures for patients.